|
Volumn 13, Issue 2, 2008, Pages 150-155
|
A retrospective study of second-line chemotherapy for unresectable or recurrent squamous cell carcinoma of the esophagus refractory to chemotherapy with 5-fluorouracil plus platinum
|
Author keywords
Docetaxel; Esophageal cancer; Nedaplatin; Second line chemotherapy; Vindesine
|
Indexed keywords
CISPLATIN;
DOCETAXEL;
FLUOROURACIL;
NEDAPLATIN;
VINDESINE;
ADULT;
AGED;
ANEMIA;
ANOREXIA;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER GROWTH;
CANCER RADIOTHERAPY;
CANCER SURVIVAL;
CAUSE OF DEATH;
CLINICAL ARTICLE;
DISEASE COURSE;
DISEASE FREE SURVIVAL;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG WITHDRAWAL;
ESOPHAGUS CARCINOMA;
FATIGUE;
FEBRILE NEUTROPENIA;
FEMALE;
HUMAN;
INOPERABLE CANCER;
LEUKOPENIA;
MALE;
MULTIPLE CYCLE TREATMENT;
NAUSEA;
NEUTROPENIA;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
RECURRENT CANCER;
RETROSPECTIVE STUDY;
SQUAMOUS CELL CARCINOMA;
SURVIVAL RATE;
SURVIVAL TIME;
THERAPY EFFECT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
TREATMENT RESPONSE;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SQUAMOUS CELL;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
ESOPHAGEAL NEOPLASMS;
FEMALE;
FLUOROURACIL;
HUMANS;
MALE;
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
RETROSPECTIVE STUDIES;
SURVIVAL ANALYSIS;
TAXOIDS;
TREATMENT OUTCOME;
VINDESINE;
|
EID: 43449089197
PISSN: 13419625
EISSN: None
Source Type: Journal
DOI: 10.1007/s10147-007-0738-y Document Type: Article |
Times cited : (17)
|
References (14)
|